Related Experiment Video
Updated: Jun 16, 2026

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining
Published on: December 23, 2014
Glycogenin-1 deficiency: a case report and review of the literature
Nicola Molitierno1, Daniele Velardo2, Giulia Salvucci1
1Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.
Abstract:
Pathogenic biallelic variants in GYG1, encoding for glycogenin-1, are associated with polyglucosan bodies myopathy characterized by muscle accumulation of deposits of amylopectin-like polysaccharides (MIM 616199). So far, only few cases (<50) with molecular defects in GYG1 have been reported. The proband is a 79-year-old Italian woman presenting with subacute onset of diffuse soreness, weakness in the upper limbs and diffuse muscle atrophy without cardiac or respiratory involvement. Electromyography showed myopathic features. Muscle biopsy revealed several type I muscle fibers containing intensely PAS-positive, diastase-resistant vacuoles of variable dimension. Ultrastructural analysis showed vacuoles with granular-fibrillar storage material localized in subsarcolemmal and intermyofibrillar areas, small amounts of free glycogen and jagged Z-line appearance of some sarcomeres. Clinical exome sequencing revealed two heterozygous pathogenic variants in GYG1. Our findings provide clinical and molecular characterization of a novel case of GYG1-related polyglucosan bodies myopathy and highlight the histological clues leading to the diagnosis of this rare clinical phenotype.
Related Concept Videos
Hypoglycemia and Glucagon
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Type I Diabetes III: Clinical Manifestations
Hyperglycemia
Type I Diabetes II: Pathophysiology
